13.91
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CC?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$13.57
Offen:
$13.61
24-Stunden-Volumen:
4.12M
Relative Volume:
0.99
Marktkapitalisierung:
$2.08B
Einnahmen:
$5.75B
Nettoeinkommen (Verlust:
$77.00M
KGV:
28.39
EPS:
0.49
Netto-Cashflow:
$-675.00M
1W Leistung:
+5.62%
1M Leistung:
+29.64%
6M Leistung:
-29.75%
1J Leistung:
-42.04%
Chemours Company Stock (CC) Company Profile
Firmenname
Chemours Company
Sektor
Branche
Telefon
302 773 1000
Adresse
1007 MARKET STREET, WILMINGTON, DE
Vergleichen Sie CC mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
CC
Chemours Company
|
13.91 | 1.97B | 5.75B | 77.00M | -675.00M | 0.49 |
![]()
LIN
Linde plc Ordinary Share
|
472.02 | 216.80B | 33.02B | 6.61B | 4.91B | 13.77 |
![]()
SHW
Sherwin Williams Co
|
340.07 | 84.97B | 23.04B | 2.68B | 2.18B | 10.58 |
![]()
ECL
Ecolab Inc
|
270.55 | 75.08B | 15.68B | 2.10B | 1.50B | 7.36 |
![]()
APD
Air Products Chemicals Inc
|
298.13 | 63.79B | 12.02B | 1.53B | -4.33B | 6.88 |
![]()
DD
Dupont De Nemours Inc
|
77.54 | 31.00B | 12.52B | -75.00M | 1.27B | -0.19 |
Chemours Company Stock (CC) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-03-27 | Hochstufung | Mizuho | Neutral → Outperform |
2025-01-28 | Eingeleitet | Truist | Buy |
2024-07-09 | Hochstufung | UBS | Neutral → Buy |
2024-06-07 | Eingeleitet | Mizuho | Neutral |
2024-04-09 | Hochstufung | BMO Capital Markets | Underperform → Outperform |
2024-03-05 | Herabstufung | UBS | Buy → Neutral |
2024-02-29 | Herabstufung | BMO Capital Markets | Outperform → Underperform |
2023-12-01 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
2023-06-22 | Herabstufung | BofA Securities | Buy → Neutral |
2023-01-24 | Hochstufung | UBS | Neutral → Buy |
2023-01-11 | Hochstufung | BofA Securities | Neutral → Buy |
2023-01-10 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
2022-11-01 | Eingeleitet | Credit Suisse | Underperform |
2022-10-13 | Eingeleitet | Goldman | Neutral |
2022-10-05 | Herabstufung | Argus | Buy → Hold |
2022-06-14 | Herabstufung | BofA Securities | Buy → Neutral |
2021-06-10 | Eingeleitet | Wolfe Research | Outperform |
2021-06-09 | Hochstufung | Goldman | Neutral → Buy |
2021-05-20 | Eingeleitet | BofA Securities | Buy |
2021-05-06 | Hochstufung | Argus | Hold → Buy |
2021-01-08 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
2020-12-04 | Herabstufung | Barclays | Overweight → Equal Weight |
2020-11-30 | Eingeleitet | Alembic Global Advisors | Overweight |
2020-03-23 | Herabstufung | Jefferies | Buy → Hold |
2020-02-14 | Hochstufung | CFRA | Buy → Strong Buy |
2019-11-06 | Hochstufung | CFRA | Hold → Buy |
2019-08-20 | Hochstufung | Susquehanna | Neutral → Positive |
2019-08-09 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
2019-08-06 | Herabstufung | Argus | Buy → Hold |
2019-08-05 | Herabstufung | SunTrust | Buy → Hold |
2019-07-12 | Herabstufung | Citigroup | Buy → Neutral |
2019-05-06 | Herabstufung | JP Morgan | Overweight → Neutral |
2019-04-15 | Hochstufung | SunTrust | Hold → Buy |
2019-02-19 | Herabstufung | Susquehanna | Positive → Neutral |
2019-01-08 | Eingeleitet | HSBC Securities | Buy |
2019-01-04 | Hochstufung | Citigroup | Neutral → Buy |
2018-11-02 | Herabstufung | Citigroup | Buy → Neutral |
2018-07-18 | Eingeleitet | RBC Capital Mkts | Outperform |
2018-01-30 | Eingeleitet | Morgan Stanley | Equal-Weight |
2017-12-06 | Herabstufung | Goldman | Buy → Neutral |
2017-08-07 | Hochstufung | UBS | Sell → Neutral |
Alle ansehen
Chemours Company Aktie (CC) Neueste Nachrichten
What drives The Chemours Company stock priceFree Stock Market Return Analysis - jammulinksnews.com
What analysts say about The Chemours Company stockUnstoppable investment returns - jammulinksnews.com
Is The Chemours Company a good long term investmentFree Trading Strategy Suggestions - jammulinksnews.com
The Chemours Company Stock Analysis and ForecastExplosive earnings growth - Autocar Professional
Lobbying Update: $760,000 of THE CHEMOURS COMPANY lobbying was just disclosed - Quiver Quantitative
Residents fight back as chemical manufacturer looks to make major expansion: 'We think it's a terrible idea' - The Cool Down
Zuid-Holland approves Chemours permit to emit toxic PFAS byproduct - NL Times
Refrigerants Industry Company Evaluation Report 2025 | Honeywell and Chemours Lead Global Market with Strategic Initiatives, Linde PLC Strengthens Position through Innovation and Expansion - Yahoo Finance
Engineered Fluids Market Surges Amid Booming Demand - openPR.com
Louisville water utility links toxic PFAS spike to West Virginia chemical plant - ehn.org
New Jersey’s PFAS trial against DuPont, Chemours opens in federal court - MSN
Lobbying Update: $90,000 of THE CHEMOURS COMPANY lobbying was just disclosed - Quiver Quantitative
Chemours Appoints Matthew Conti as Chief Human Resources Officer - MSN
Chemours names Google executive Joseph Kava to board of directors - TipRanks
Q&A With Chemours Chief Sustainability Officer, Kathy O’Keefe - CSRwire
Chemours (CC) Maintains Outperform Rating as Mizuho Raises Price Target | CC Stock News - GuruFocus
Chemours (CC) Receives Upgraded Price Target from Mizuho | CC St - GuruFocus
Q&A With Chemours Chief Sustainability Officer, Kathy O'Keefe - ReportAlert
Digging In: Why a West Virginia factory’s pollution could trouble Louisville’s drinking water - Louisville Public Media
What To Know About PFAS In Delaware: Local Impacts, Risks, And What’s Being Done - townsquaredelaware.com
Chemours Updates Second Quarter 2025 Outlook with Strong Gains in Key Segments - MSN
Opacifiers Market is Projected with a Value of USD 32.47 Billion by 2032, Driven by Sustainable Architectural Coatings and EV Plastics Demand | Report by SNS Insider - GlobeNewswire Inc.
Chemours Stock Soars 2.03% on EPA Regulatory Relief - AInvest
Chemours, Koura file replies in support of dismissing US antitrust claims over refrigerants - MLex
Chemours (CC) Surges 9.7% as EPA Withdraws Ban on Chrysotile Asbestos - Insider Monkey
Despite Lagging Supply Chain, Chemours Reports Net Sales of $1.7 Billion in Third Quarter - Coatings World
Chemours, Other Chemical Manufacturer Stocks Rise as EPA Pulls Back on New Use Rules - MarketScreener
Stocks making the biggest moves midday: Hershey, Chemours, Fair Isaac, Sunrun and more - CNBC
Chemours surges to highest since March as EPA pulls plan to rewrite asbestos phaseout rule - Seeking Alpha
Green Group, Chemours Battle Over W.Va. PFAS Injunction Ask - Law360
The Chemours Company's (NYSE:CC) Price Is Right But Growth Is Lacking After Shares Rocket 30% - simplywall.st
Chemours (CC) Maintains Outperform Rating with Raised Price Target | CC Stock News - GuruFocus
Chemours DeLisle Inspires Future STEM Leaders Through Hands-On Learning - CSRwire
RBC Raises Price Target on Chemours to $15 From $14, Keeps Outperform Rating - MarketScreener
Chemours Company (CC) Receives a Buy from UBS - The Globe and Mail
UBS reiterates Buy rating on Chemours stock, citing datacenter cooling potential - Investing.com
Chemours' Index Demotion: A Mirror of Financial Strains and Valuation Risks - AInvest
Investors who lost money on The Chemours Company should contact Levi & Korsinsky about an ongoing investigationCC - ACCESS Newswire
Chemours (NYSE:CC) Has No Shortage Of Debt - simplywall.st
Chemours Loses Bid To Keep Disclosures Suit Details Sealed - Law360
Pesky PFAS present in Louisville water, data show - Louisville Public Media
Analysts Conflicted on These Materials Names: Chemours Company (CC), Agnico Eagle (AEM) and Olin (OLN) - The Globe and Mail
Chemours (CC) Q2 EBITDA Forecast Falls Short but Long-Term Growt - GuruFocus
Chemours (CC) Shares Rise on Positive Q2 Outlook - GuruFocus
Chemours foresees strong Q2 sales increase on strong refrigerant demand (CC:NYSE) - Seeking Alpha
Chemours stock falls after Truist maintains buy rating despite guidance cut - Investing.com India
The Chemours Company Provides Earnings Guidance for the Second Quarter 2025 - MarketScreener
Chemours stock rises on strong refrigerant demand, raises Q2 outlook By Investing.com - Investing.com India
Finanzdaten der Chemours Company-Aktie (CC)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):